Status:

COMPLETED

Evaluate the Relevance of the Use of Peripheral Venous Blood Gases for the Care of Patients in the S.A.U.V (Vital Emergency Rooms) of the CHU de Caen

Lead Sponsor:

University Hospital, Caen

Conditions:

Critical Illness

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

concordance between the lactate values on peripheral venous and arterial blood gases in all patients receiving an arterial sample on their arrival in the S.A.U.V.

Eligibility Criteria

Inclusion

  • one of this condition in emergency unit :
  • acute respiratory distress
  • a suspicion of an acid-base disorder
  • a state of shock
  • Pathologies requiring monitoring of the respiratory system
  • Patient under NIV
  • Poisoning
  • Coma with a Glasgow score \< or equal to 8

Exclusion

  • Patient presenting another pathology supported in SAUV not requiring the realization of arterial blood gases
  • Patient aged \< 18 years
  • Pregnant or breastfeeding woman

Key Trial Info

Start Date :

January 15 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 18 2020

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT05971615

Start Date

January 15 2020

End Date

December 18 2020

Last Update

August 2 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CAEN University Hospital

Caen, France

Evaluate the Relevance of the Use of Peripheral Venous Blood Gases for the Care of Patients in the S.A.U.V (Vital Emergency Rooms) of the CHU de Caen | DecenTrialz